Product
Supplier
Encyclopedia
Inquiry
Home > Encyclopedia > ara-AMP

ara-AMP

pharmaceutical raw materials
ara-AMP structure

ara-AMP 

structure
  • CAS No:

    29984-33-6

  • Formula:

    C10H14N5O7P

  • Chemical Name:

    ara-AMP

  • Synonyms:

    9H-Purin-6-amine,9-(5-O-phosphono-β-D-arabinofuranosyl)-;Adenine,9-β-D-arabinofuranosyl-,5′-(dihydrogen phosphate);9-(5-O-Phosphono-β-D-arabinofuranosyl)-9H-purin-6-amine;9-β-D-Arabinofuranosyladenine monophosphate;Adenine arabinonucleoside 5′-phosphate;5′-Arabinosyladenine monophosphate;D-Arabinosyladenine 5′-monophosphate;9-β-D-Arabinofuranosyladenine 5′-monophosphate;9-β-D-Arabinofuranosyladenine 5′-phosphate;9-β-D-Arabinofuranosyl AMP;Arabinosyladenine monophosphate;Adenine arabinoside monophosphate;Vidarabine monophosphate;Vidarabine-5′-monophosphate;ara-AMP;Adenine arabinoside 5′-monophosphate;Vidarabine phosphate;CI 808;NSC 127223

  • Categories:

    Biochemical Engineering  >  Saccharides

Description

Crystalline


Vidarabine Phosphate is a phosphate salt form of vidarabine, a nucleoside analog with activity against herpes simplex virus and varicella zoster virus. Vidarabine is converted to a monophosphate by viral thymidine kinase and is further modified to a triphosphate form by host enzymes. Vidarabine triphosphate directly inhibits DNA polymerase and also acts as a chain terminator in DNA replication.|An adenosine monophosphate analog in which ribose is replaced by an arabinose moiety. It is the monophosphate ester of VIDARABINE with antiviral and possibly antineoplastic properties.

ara-AMP Basic Attributes

347.22

347.22

249-990-8

106XV160TZ

C90789

29400090

Characteristics

195.88000

-0.22

White to Off-white Powder

2.3±0.1 g/cm3

213 °C

798.5±70.0 °C at 760 mmHg

436.7±35.7 °C

1.905

soluble in water at 4mg/ml

Store at 0°C

Abdominal-rat LD50: 1700 mg/kg; Abdominal-mouse LD50: 1200 mg/kg

The warehouse is ventilated and dried at low temperature; stored dry powder, foam, sand, carbon dioxide, and spray water separately from food raw materials; combustible; burning produces toxic nitrogen oxides and phosphorus oxide fumes

Safety Information

II

6.1(a)

2811

20/22-40-23/24/25-36/37/38

37/39-24/25-45-36/37/39-22-36-26

AU6204000

Xn,T,Xi

Warehouse ventilated, low temperature and dry

Toxicity

moderately toxic

Drug Information

Drugs that are chemically similar to naturally occurring metabolites, but differ enough to interfere with normal metabolic pathways. (From AMA Drug Evaluations Annual, 1994, p2033) (See all compounds classified as Antimetabolites.)|Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. (See all compounds classified as Antiviral Agents.)

9-(5-O-Phosphono-beta-D-arabinofuranosyl)-9H-purin-6-amine

ara-AMP Use and Manufacturing

Antiviral.

Computed Properties

Molecular Weight:347.22
XLogP3:-3.5
Hydrogen Bond Donor Count:5
Hydrogen Bond Acceptor Count:11
Rotatable Bond Count:4
Exact Mass:347.06308480
Monoisotopic Mass:347.06308480
Topological Polar Surface Area:186
Heavy Atom Count:23
Complexity:481
Defined Atom Stereocenter Count:4
Covalently-Bonded Unit Count:1
Compound Is Canonicalized:Yes

Drug Function and Efficacy

This product is an anti-deoxyribonucleic acid (DNA) virus drug. Its pharmacological action is to bind to the viral deoxyribonucleic acid polymerase, reduce its activity and inhibit DNA synthesis. After entering the cell, adenosine monophosphate is phosphorylated to generate adenosine diphosphate (Ara-ADP) and adenosine triphosphate (Ara-ATP). The antiviral activity is mainly caused by adenosine triphosphate (Ara-ATP). Ara-ATP and deoxyadenosine triphosphate (dATP) compete to bind to viral DNAP, thereby inhibiting the activity of the enzyme and the synthesis of viral DNA. At the same time, it inhibits the activity of viral nucleotide reductase and inhibits the synthesis of viral DNA. It can also inhibit the activity of viral DNA terminal deoxynucleotidyl transferase, so that Ara-A penetrates into the viral DNA and connects to the end of the DNA chain 3prime;-OH position, inhibiting the continued synthesis of viral DNA.

This ingredient has been used in drugs with the following functions (note: it does not mean that the ingredient itself has the following health functions)

Related Drugs

Registered Holders

  • Hainan Huluwa Pharmaceutical Group Co., Ltd.

    China China
    Active
  • China Resources Double-Crane Pharmaceutical Co., Ltd.

    China China
    Active
  • Waterstone Pharmaceuticals (HuBei) Co., Ltd.

    China China
    Active

Recommended Suppliers of ara-AMP

Scan the QR Code to Share

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.